All In Biotech

NDA 019904 · Baxter Hlthcare

Potassium Chloride 20meq In Plastic Container

Potassium Chloride · Injection

Last checked: Nov 20, 2026Latest source record: Jun 13, 2024 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1989

Dec 26, 1989

Approved uses

1

Original approval plus efficacy supplements

Registered trials

9,299

2,122 Phase 3, 968 recruiting

FAERS reports

93,810

69,872 serious, 13,688 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Jan 9, 2026.

INDICATIONS AND USAGE Potassium Chloride Injection is indicated in the treatment of potassium deficiency states when oral replacement is not feasible. THIS HIGHLY CONCENTRATED, READY-TO-USE POTASSIUM CHLORIDE INJECTION IS INTENDED FOR THE MAINTENANCE OF SERUM K + LEVELS AND FOR POTASSIUM SUPPLEMENTATION IN FLUID RESTRICTED PATIENTS WHO CANNOT ACCOMMODATE ADDITIONAL VOLUMES OF FLUID ASSOCIATED WITH POTASSIUM SOLUTIONS OF LOWER CONCENTRATION. When using these products, these patients should be on continuous cardiac monitoring and frequent testing for serum potassium concentration and acid-base balance.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Dec 26, 1989 Original approval · Type 5 - New Formulation or New Manufacturer
6 products under this application
  • POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 1.49GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 2.98GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 29.8MG/ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 746MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 2.24GM/100ML · INJECTABLE, INJECTION · Discontinued
  • POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 14.9MG/ML · INJECTABLE, INJECTION · Prescription · TE AP

Clinical trials

Interventional ClinicalTrials.gov studies with "Chloride" as an intervention, any sponsor and status, largest first.

All 9,299 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • diarrhoea6,883
  • dyspnoea6,837
  • nausea6,626
  • fatigue6,413
  • death4,665
  • pneumonia4,544
  • headache4,281
  • vomiting4,214
  • asthenia4,206
  • off label use4,119
  • dizziness4,050
  • pain3,918

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004901
20051,824
20061,348
20071,683
20082,435
20092,665
20102,185
20112,586
20123,567
20132,072
20142,479
20153,923
20164,697
20174,797
20185,789
20195,658
20205,668
20216,017
20226,667
20236,693
20247,494
20257,576
20265,080

Recalls

3 FDA enforcement reports for this application.

  • Nov 10, 2014 · Class II · Terminated

    Labeling: Label Error On Declared Strength: Bags of Potassium Chloride 10 mEq per 100 mL were incorrectly overpouched with wraps labeled as Potassium Chloride Injection, 20 mEq per 100 mL.

  • Sep 8, 2014 · Class II · Terminated

    Correct Labeled Product Mispack: Shipping cartons labeled as containing Potassium Chloride injection actually contained bags labeled and containing Gentamicin Sulfate injection inside.

  • Jul 11, 2014 · Class I · Terminated

    Presence of Particulate Matter: particulate matter identified as fibers and/or plastics

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 4,091 on PubMed

Sponsor: Baxter Hlthcare · Also marketed as Potassium Chloride 40meq In Plastic Container, Potassium Chloride 10meq In Plastic Container, Potassium Chloride 30meq In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.